How do you calculate a norepinephrine (vasopressor) drip dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Calculate Norepinephrine Drip Dose

The standard norepinephrine drip is prepared by adding 4 mg of norepinephrine to 250 mL of D5W, yielding a concentration of 16 mcg/mL, with initial dosing starting at 0.1-0.5 mcg/kg/min (or 7-35 mcg/min in a 70 kg adult) and titrated to achieve a mean arterial pressure of 65 mmHg. 1, 2

Standard Concentration Preparation

  • Add 4 mg (4 mL) of norepinephrine to 1,000 mL of 5% dextrose solution to create a concentration of 4 mcg/mL 2
  • Alternatively, add 4 mg of norepinephrine to 250 mL of D5W to yield a more concentrated solution of 16 mcg/mL 1
  • Dextrose-containing solutions are essential as they protect against significant loss of potency due to oxidation; administration in saline alone is not recommended 2
  • Solutions remain chemically stable for seven days at room temperature under ambient light when diluted in either D5W or normal saline 3

Initial Dosing and Titration

  • Start at 2-3 mL/min (8-12 mcg/min) using the 4 mcg/mL concentration, then titrate to maintain systolic blood pressure of 80-100 mmHg 2
  • Using weight-based dosing: initiate at 0.1-0.5 mcg/kg/min, which translates to 7-35 mcg/min in a 70 kg adult 1
  • The average maintenance dose ranges from 0.5-1 mL/min (2-4 mcg/min of base) using the standard 4 mcg/mL concentration 2
  • Titrate dose every 4 hours as needed, increasing by 0.5 mg/h increments up to a maximum of 3 mg/h 1

Target Blood Pressure Goals

  • Target mean arterial pressure (MAP) of 65 mmHg for septic shock 1
  • In previously hypertensive patients, raise blood pressure no higher than 40 mmHg below the pre-existing systolic pressure 2
  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 1

Critical Pre-Administration Requirements

  • Address hypovolemia FIRST with a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation 1
  • In severe hypotension (systolic <70 mmHg), start norepinephrine as an emergency measure while fluid resuscitation continues, rather than waiting for complete volume repletion 1
  • Vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure 1

Administration Route and Safety

  • Central venous access is strongly preferred to minimize extravasation risk 1, 2
  • If central access is unavailable or delayed, peripheral IV can be used temporarily with strict monitoring 1
  • Insert a plastic IV catheter well advanced centrally into the vein and securely fixed with adhesive tape 2
  • Use an IV drip chamber or metering device to permit accurate estimation of flow rate in drops per minute 2

Extravasation Management

  • If extravasation occurs, immediately infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline at the site to prevent tissue necrosis 1, 2
  • Pediatric phentolamine dose: 0.1-0.2 mg/kg up to 10 mg 1

Special Dosing Considerations

Pediatric Dosing

  • Standard pediatric dosing ranges from 0.1-1.0 mcg/kg/min, starting at the lowest dose and titrating to effect 1
  • Doses as high as 5 mcg/kg/min may be necessary in children 1
  • "Rule of 6" for pediatric infusions: 0.6 × body weight (kg) = number of milligrams diluted to total 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min 1

Obese Patients

  • Obese patients require lower weight-based doses (0.09 mcg/kg/min) compared to non-obese patients (0.13 mcg/kg/min) 4
  • However, total non-weight-based doses are similar between obese and non-obese patients (approximately 8-9 mcg/min) 4

Alternative Concentration for Anaphylaxis

  • For anaphylaxis requiring continuous infusion: add 1 mg of norepinephrine to 100 mL of saline to create a 1:100,000 solution (10 mcg/mL) 1
  • Administer at an initial rate of 30-100 mL/h (5-15 mcg/min), titrated based on clinical response 1

Monitoring and Titration Endpoints

  • Titrate to achieve target MAP and markers of tissue perfusion including lactate clearance, urine output (>50 mL/h), mental status, and capillary refill 1
  • When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin (0.03-0.04 units/min) as second-line therapy rather than continuing to escalate norepinephrine alone 1
  • Place an arterial catheter as soon as practical for continuous monitoring 1

Important Precautions

  • Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions in the IV line, as adrenergic agents are inactivated in alkaline solutions 1, 2
  • Watch for potential side effects including hypertension, arrhythmias, tissue ischemia, cold extremities, and decreased urine output 1
  • Reduce infusion gradually when discontinuing; avoid abrupt withdrawal 2
  • Great individual variation occurs in required doses; occasionally doses as high as 68 mg base (17 vials) daily may be necessary, but always suspect and correct occult blood volume depletion 2

References

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Stability of norepinephrine infusions prepared in dextrose and normal saline solutions.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2008

Research

Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.